State AGs Want Stay Lifted In Generic Drug Pricing Suit

By Brian Steele · June 27, 2024, 10:27 PM EDT

The attorneys general of New York and Connecticut have asked a federal judge to lift a partial discovery stay in three state-led generic drug pricing lawsuits against the pharmaceutical industry, saying...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Connecticut et al v. Aurobindo Pharma USA, Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

December 15, 2016

Case Title

Connecticut et al v. Teva Pharmaceuticals USA, Inc.

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

May 10, 2019

Case Title

Connecticut et al v. Sandoz, Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

June 10, 2020

Recent Articles By Brian

June 24, 2024
Judge Mulls BioXcel's Duty To Tell Investors Of FDA Troubles
June 24, 2024
Justices Pass On Conn. School Vaccine Mandate Fight
June 20, 2024
HHS Drug Pricing Program Flouts Constitution, Boehringer Says
June 13, 2024
Feds Get $4.6M In Deal Over Telehealth Billing Fraud Probe
June 07, 2024
Conn. Judge Pushes State For Proof In $11M Kickback Case
June 07, 2024
7 Health Insurers Eye Rate Hikes In Connecticut
May 23, 2024
Conn. Marketing Co., Competitor Settle Exec Poaching Suit
April 30, 2024
Aetna Resists State Court Remand In Provider Payment Suit
April 24, 2024
Conn. Healthcare Co. Will Pay $1.5M To End Data Breach Suit
April 18, 2024
Conn. Marketing Co. Says Competitor Poached Top Exec